BRAF and melanoma: Overall, BRAF mutation prevalence in human cancers is almost 100% for hairy cell leukemia, 50% for melanoma, 45% for papillary thyroid cancer, 10% for colon cancer, and 10% for non-small cell lung cancer cases [61].